Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy

Glioblastoma, the most common primary brain cancer in adults, is characterized by a poor prognosis and resistance to standard treatments. The advent of immunotherapy has revolutionized the treatment of several cancers in recent years but has failed to demonstrate benefit in patients with glioblastom...

詳細記述

書誌詳細

出版年:	Biology
主要な著者:	Catherine Yu, Kristin Hsieh, Daniel R. Cherry, Anthony D. Nehlsen, Lucas Resende Salgado, Stanislav Lazarev, Kunal K. Sindhu
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2023-12-01
主題:	glioblastoma tumor microenvironment immune checkpoint inhibitors chimeric antigen receptor (CAR) T-cell therapy immunotherapy resistance immunosuppression
オンライン･アクセス:	https://www.mdpi.com/2079-7737/12/12/1528